Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of thyroid neoplasm or benign goiter~* Scheduled for BABA endoscopic or robotic thyroidectomy~Exclusion Criteria:~* Completion thyroidectomy~* Modified radical neck dissection~* Allergy history~* Stroke history~* Uncontrolled hypertension~* Uncontrolled diabetes~* Coagulopathy~* Severe cardiovascular disease~* Severe pulmonary disease~* Chronic kidney disease~* Pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): 100cc normal saline is injected into the subcutaneous layer for the initial flap dissection.
- Ropivacaine with epinephrine injection (Type: EXPERIMENTAL): 1 mg/mL 1cc epinephrine is diluted in 100cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.

Based on this trial design, predict the completion outcome and termination type (if applicable).